Lowering of circulating free-fatty acids levels and reduced expression of leptin in white adipose tissue in postobesity status

Journal of Investigative Medicine

Volumn 50, Issue 3, 2002, Pages 207-213

  Greco, Aldo V ^a   Mingrone, Geltrude ^a   Vettor, Roberto ^a   Manco, Melania ^a   Rosa, Giuseppina ^a   Capristo, Esmeralda ^a   Federspil, Giovanni ^a   Castagneto, Marco ^a   Gasbarrini, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Biliopancreatic diversion; Free fatty acids; Leptin; Morbid obesity

Indexed keywords

FATTY ACID; INSULIN; LEPTIN; MESSENGER RNA;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; LONGITUDINAL STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; MORBID OBESITY; RADIOIMMUNOASSAY; SUBCUTANEOUS TISSUE; WHITE ADIPOSE TISSUE;

EID: 0036097248     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2002.33435     Document Type: Article

References (62)

1. Weight-reducing effects of the plasma protein encoded by the obese gene
2. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
3. Depot-and sex-specific differences in human leptin mRNA expression: Implications for the control of regional fat distribution
4. A pathogenic role of visceral fat β-3-adrenoceptors in obesity
5. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
6. Relationship between weight loss maintenance and changes in serum leptin levels
7. Responses of leptin to short-term fasting and refeeding in humans: A link with ketogenesis but not ketones themselves
8. Evidence of free and bound leptin in human circulation: Studies in lean and obese subjects and during short-term fasting
9. Short- and long-term changes in serum leptin dieting obese women: Effects of caloric restriction and weight loss
10. Serum leptin and weight loss in severely obese patients undergoing biliopancreatic diversion
11. Plasma leptin levels after biliopancreatic diversion: Dissociation with body mass index
12. Short-term changes in serum leptin concentration following biliopancreatic diversion
13. Glucose-induced thermogenesis in postobese women who have undergone biliopancreatic diversion
14. Normalization of insulin sensitivity in the obese patient after stable weight reduction with biliopancreatic diversion
15. Twenty-four-hour energy and nutrient balance in weight stable postobese patients after biliopancreatic diversion
16. Reversibility of insulin resistance in obese diabetic patients: Role of plasma lipids
17. Bilio-pancreatic bypass for obesity: II. Initial experience in man
18. Biliopancreatic diversion: Two decades of experience
19. Total body water and the exchangeable hydrogen: I. Theoretical calculation of nonaqueous exchangeable hydrogen in man
20. Body composition of humans: Comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure
21. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women
22. Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-γ2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-a gene expression in human subcutaneous fat by lipid infusion
23. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
24. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: Effects of dietary fat content and sustained weight loss
25. Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice
26. Early and late stimulation of ob mRNA expression in meal-fed and overfed rats
27. Plasma leptin and insulin levels in weight-reduced obese women with normal body mass index: Relationships with body composition and insulin
28. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
29. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
30. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes
31. Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance
32. Response of leptin to short-term and prolonged overfeeding in humans
33. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue
34. Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance?
35. Insulin stimulates both leptin secretion and production by rat white adipose tissue
36. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes
37. Expression of ob gene in adipose cells: Regulation by insulin
38. Regulation of ob gene mRNA levels in cultured adipocytes
39. Diet- and diabetes-induced changes of ob gene expression in rat adipose tissue
40. Gene expressions of leptin, insulin receptors and lipogenic enzymes are coordinately regulated by insulin and dietary fat in rats
41. Splanchnic insulin metabolism in obesity: Influence of body fat distribution
42. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
43. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat
44. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation
45. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans
46. + channel-independent insulinotropic action of glucose
47. Fatty acids, lipotoxicity and insulin secretion
48. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency
49. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids
50. Skeletal muscle triglyceride levels are inversely related to insulin action
51. The effect of insulin on the disposal of intravenous glucose: Results from indirect calorimetry and hepatic and femoral venous catheterization
52. Tissue oxidative capacity, fuel stores and skeletal muscle fatty acid composition in obesity-prone and obesity-resistant rats
53. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat
54. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
55. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat
56. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: Parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA
57. Intramuscular triglyceride and muscle insulin sensitivity: Evidence for a relationship in nondiabetic subjects
58. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus
59. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women
60. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides
61. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity